Abstract
In a screen for Drosophila genes that interfere with transcriptional repression mediated by the Polycomb group of genes, we identified a dominant mutation affecting the Alhambra (Alh) gene, the fly homologue of the human AF10 gene. AF10 has been identified as a fusion partner of both MLL and CALM in infant leukemias. Both fusion proteins retain the leucine zipper domain of AF10 but not its PHD domain. We show here that, while the full-length ALH protein has no activity on Polycomb group-responsive elements (PREs), overexpression of the isolated ALH leucine zipper domain activates several PREs. Within the ALH full-length protein, the PHD domain inhibits the PRE deregulation mediated by the leucine zipper domain. This deregulation is conserved in the human AF10 leucine zipper domain, which confers the same activity on an oncogenic MLL-AF10 fusion protein expressed in Drosophila melanogaster. These data reveal new properties for the leucine zipper domain and thus might provide new clues to understanding the mechanisms by which AF10 fusion proteins in which the PHD domain is lost might trigger leukemias in humans.
ACKNOWLEDGMENTS
We are particularly indebted to S. Bahri for fly stocks, plasmids, and antibody, to G. F. DiMartino and M. L. Cleary for MLLNter and MLL-AF10 cDNAs, and to L. Ringrose for comments on the manuscript. We thank G. Cavalli, J. Kassis, T. Kaufman, P. Schedl, and L. Theodore for fly stocks. We thank Siegfried Bozza for precious help in polytene chromosome immunostaining. We also thank M. Sémériva for helpful discussions.
Postdoctoral training from the Indo-French Centre for the Promotion of Advanced Research (IFCPAR) and the Société de Secours des Amis des Sciences supported L.P. S.B. was supported by a predoctoral fellowship from the Ministère de l'Education Nationale and by a grant from the Association pour la Recherche sur le Cancer. This work was supported by grants from the IFCPAR (project no. 1603-1), the Centre National de la Recherche Scientifique (ATIPE no. 7), the Association pour la Recherche sur le Cancer (no. 5658), and also the Fondation pour la Recherche Médicale.